A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer

Clinical trial NCT05963867 · RECRUITING

Trial details

NCT number: NCT05963867
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Carcinoma (SCLC)Neuroendocrine Neoplasms

Start date: 2024-08-06
Primary completion: 2026-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.